Advertisement

Topics

AbbVie stops enrolment in all studies of Depatux-M after late-stage failure in newly diagnosed glioblastoma https://www.firstwordpharma.com/node/1641756  $ABBV

12:06 EDT 17 May 2019 | FirstWord Pharma

AbbVie stops enrolment in all studies of Depatux-M after late-stage failure in newly diagnosed glioblastoma https://www.firstwordpharma.com/node/1641756 

Original Article: AbbVie stops enrolment in all studies of Depatux-M after late-stage failure in newly diagnosed glioblastoma https://www.firstwordpharma.com/node/1641756  $ABBV

NEXT ARTICLE

More From BioPortfolio on "AbbVie stops enrolment in all studies of Depatux-M after late-stage failure in newly diagnosed glioblastoma https://www.firstwordpharma.com/node/1641756  $ABBV"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...